It's time forMohs: Micrographic surgery for the treatment of high‐risk basal cell carcinomas of the head and neck regions
- 11 May 2020
- journal article
- research article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 33 (4) , e13474
Abstract
Basal cell carcinoma (BCC) is the most common variety of non‐melanoma skin cancer and its incidence is rising worldwide. The centrofacial sites (area H) are considered a high risk factor for BCC local recurrence. Mohs micrographic surgery (MMS) is a technique that allows intraoperative microscopic control of the surgical margins and is a good treatment option when tissue conservation is required for aesthetic or functional reasons or for high‐risk lesions. The present study aimed to evaluate the recurrence rate of head and neck high‐risk BCCs comparing MMS versus conventional surgical excision. Clinical data of patients diagnosed from September 2014 to March 2017, referring to the Dermatology Unit of the Policlinico Sant'Orsola‐Malpighi, University of Bologna, were retrospectively evaluated (285 treated with MMS and 378 treated with traditional surgery). Of the 285 patients treated with MMS, 9 experienced a recurrence (3.1%). Of the 378 patients treated with traditional surgery, 53 relapsed (14%), 13 of whom presented residual tumour on the deep or lateral margins of the main surgical specimen. Our study confirms the trend reported in the literature that MMS represents the best treatment option for high‐risk BCCs arising in the head and neck region or presenting as a recurrence (p<0.00001). Many more MMS centres and more trained dermatologists are needed worldwide in order to deal with the increasing number of BCC diagnosed every year.Keywords
This publication has 31 references indexed in Scilit:
- Seven years' experience of Mohs micrographic surgery in a UK centre, and development of a UK minimum dataset and audit standardsClinical and Experimental Dermatology, 2013
- Basal cell carcinoma margin delineation: is curettage useful? A surgical and histological studyJournal of Dermatological Treatment, 2013
- Mohs surgery for squamous cell carcinoma of the nail: report of 15 cases. Our experience and a long‐term follow‐upBritish Journal of Dermatology, 2012
- AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: A report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs SurgeryJournal of the American Academy of Dermatology, 2012
- Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-upThe Lancet Oncology, 2008
- Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the FaceArchives of Dermatology, 2006
- Analysis of 197 female scalp tumors treated with Mohs micrographic surgeryJournal of the American Academy of Dermatology, 2005
- Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trialThe Lancet, 2004
- Coût de la chirurgie micrographique de Mohs dans les carcinomes basocellulairesAnnales de Dermatologie et de Vénéréologie, 2004
- Recurrence Rates of Treated Basal Cell CarcinomasThe Journal of Dermatologic Surgery and Oncology, 1992